Completing data — refresh the page later to see the latest
71997-40-5Nc1ncnc2c1ncn2[C@@H](C=O)O[C@@H](C=O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O.[Na]IHQATUPGVKMGLT-AUCRBCQYSA-N71997-40-5Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
UsesAdenosine 5′-triphosphate, periodate oxidized sodium salt has been used:as an antagonist of the purinergic receptor, P2 × 7 to inhibit P2 × 7 pathwayas a nonspecific agonist to assess the activity of P2×7-R by the mobilization of Ca2+to evaluate the physiological significance of elevated intracellular ATP levelsincreasedP2rx7expression for osteoclastogenesis inFlcn-deficient cells
General DescriptionA 2′,3′-dialdehyde derivative of ATP that is commonly used to affinity label nucleotide sites in enzymes. Acts as a specific, irreversible antagonist of P2Z/P2X7 purinergic receptors in J774 mouse macrophages. Does not affect P2γ receptors. Inhibits inflammatory pain in arthritic rat model by blocking ATP action on P2X7 receptor in nerve terminals. Also shown to irreversibly block ATP-induced Ca2+ influx in lymphocytes (100 μM). O-ATP-treated mice display better preservation and lower rate of rejection of pancreatic islet grafts with reduced Th1 transcripts.